Dermatology · Thibodaux, LA
NPI
1528259710
Since 2007
Specialty
Dermatology
Code 207N00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
416 Highway 308
Thibodaux, LA, 70301
Phone (985) 446-5888
Groups this clinician bills Medicare through
Medicare paid, 2024
$504K
15,099 services
Medicare patients, 2024
1,329
Average age 76
Drug cost, 2024
$1.2M
5,275 prescriptions
Company payments, 2025
$2,204
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ryan J Matherne was code 17003 (destruction skin lesion), 7,169 times for 814 patients. In total Ryan J Matherne billed 15,099 services in 85 codes, and Medicare paid $504K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-11-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 7,169 | 814 | $4.59 | $33K |
| 99213 Office E&M - Established | Office | 2,280 | 1,116 | $59.96 | $137K |
| 17000 Destruction Skin Lesion | Office | 1,538 | 912 | $37.42 | $58K |
| 88305 Surgical Pathology Examination | Office | 713 | 428 | $52.28 | $37K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 504 | 118 | $0.71 | $360 |
| 11102 Skin Biopsy | Office | 497 | 427 | $59.72 | $30K |
| 17110 Destruction Skin Lesion | Office | 458 | 360 | $75.82 | $35K |
| 99203 Office E&M - New | Office | 272 | 272 | $67.72 | $18K |
| 99214 Office E&M - Established | Office | 211 | 128 | $84.97 | $18K |
| 17004 Destruction Skin Lesion | Office | 194 | 131 | $113.87 | $22K |
| J0702 Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 169 | 27 | $5.41 | $914 |
| 11900 Skin | Office | 102 | 72 | $31.00 | $3,162 |
| 11103 Skin Biopsy | Office | 94 | 74 | $36.53 | $3,434 |
| 88304 Surgical Pathology Examination | Office | 91 | 74 | $30.63 | $2,787 |
| 99212 Office E&M - Established | Office | 87 | 69 | $40.88 | $3,556 |
By year: 2022 $509K for 15,212 services; 2023 $514K for 15,767 services; 2024 $504K for 15,099 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 88305 Surgical Pathology Examination | 713 | 428 | $52.28 | $37K |
| 88304 Surgical Pathology Examination | 91 | 74 | $30.63 | $2,787 |
| 88312 Surgical Pathology Examination | 32 | 20 | $82.92 | $2,653 |
| 88342 Immunohistochemistry | 27 | 24 | $76.52 | $2,066 |
| 88341 Immunohistochemistry | 26 | 15 | $65.58 | $1,705 |
Medicare prescription drug claims, 2024
In 2024, the drug Ryan J Matherne prescribed most often to Medicare patients was Triamcinolone Acetonide, with 623 prescriptions and refills. In total Ryan J Matherne wrote 5,275 Medicare prescriptions that cost $1.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Triamcinolone Acetonide Generic | 623 | 684 | 305 | $5,897 |
| Ketoconazole Generic | 579 | 653 | 221 | $8,344 |
| Hydrocortisone Generic | 503 | 546 | 283 | $2,496 |
| Betamethasone Diprop Augmented Betamethasone/Propylene Glyc | 412 | 442 | 193 | $8,145 |
| Clobetasol Propionate Generic | 400 | 451 | 199 | $17K |
| Mometasone Furoate Generic | 220 | 291 | 109 | $4,798 |
| Mupirocin Generic | 214 | 225 | 131 | $1,481 |
| Betamethasone Valerate Generic | 206 | 242 | 96 | $6,870 |
| Hydroxyzine Hcl Generic | 179 | 247 | 68 | $1,522 |
| Nystatin Generic | 153 | 167 | 71 | $1,876 |
| Clindamycin Phosphate Generic | 133 | 175 | 60 | $3,909 |
| Doxycycline Monohydrate Generic | 122 | 131 | 68 | $2,436 |
| Nystatin-Triamcinolone Nystatin/Triamcinolone Acet | 106 | 111 | 68 | $3,641 |
| Metronidazole Generic | 102 | 126 | 64 | $5,650 |
| Minocycline Hcl Generic | 100 | 138 | 50 | $1,451 |
Brand drugs: - claims; generic drugs: 4,934 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ryan J Matherne $2,204 ($2,204 in general payments such as food, travel and fees) from 19 companies. The largest payer was Abbvie Inc. with $546.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.